ContraFect to Present at 2nd International Symposium on Antimicrobial Hydrolytic Enzymes November 1, 2018
ContraFect to Present at the “Exploring the Antibiotic Pipeline 2018” Symposium and also to Present New Data on CF-301 (exebacase) at IDWeek 2018 September 25, 2018
ContraFect Completes Enrollment in Phase 2 Clinical Trial Evaluating CF-301 (exebacase) in Patients with Staphylococcus Aureus Bacteremia September 6, 2018
ContraFect to Present at ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance August 22, 2018
ContraFect to Participate in FDA Workshop on Development of Non-Traditional Therapies for Bacterial Infections August 14, 2018
